AN OPEN-LABEL, NEOADJUVANT PHASE 2 CLINICAL TRIAL COMPARING THE EFFECTS OF AR INHIBITION WITH AND WITHOUT SRC OR MEK INHIBITION ON THE DEVELOPMENT OF EMT IN PROSTATE CANCER: AN OUTCOME REPORT
JOURNAL OF UROLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要